Evaluation and Treatment of Pruritic Rash
For a patient presenting with an itchy rash, immediately determine whether primary skin lesions are present—this single distinction drives your entire diagnostic and therapeutic approach. 1, 2
Initial Clinical Assessment
Examine the skin systematically, including finger webs, anogenital region, nails, and scalp 2. Look specifically for:
- Primary lesions (papules, vesicles, plaques) = diseased/inflamed skin (Group I pruritus)
- Only secondary lesions (excoriations, lichenification) or normal skin = pruritus without dermatosis (Group II/III)
Diagnostic Algorithm
If Primary Skin Lesions Present (Group I)
The rash itself is the disease. Diagnose the specific dermatosis:
- Atopic dermatitis, eczema, psoriasis, seborrheic dermatitis
- Contact dermatitis, urticaria, scabies (check finger webs)
- Pruritic papular eruptions, folliculitis
Treatment targets the underlying skin condition, which will resolve the itch 3.
If No Primary Lesions or Only Scratch Marks (Group II/III)
Pursue systematic investigation for secondary causes 1:
Initial laboratory workup:
- Complete blood count with differential (lymphoma, polycythemia vera)
- Creatinine/BUN (uremia)
- Liver function tests (hepatic pruritus)
- Iron studies (iron deficiency)
- Fasting glucose or A1C (diabetes)
- TSH (thyroid disease)
Additional testing based on clinical suspicion:
- ESR, HIV screening, hepatitis serologies, chest X-ray 2
- In older patients with chronic generalized pruritus, strongly consider occult malignancy 2
Treatment Approach
Basic Therapy (Step 1) - All Patients
Emollients and trigger avoidance form the foundation 1:
- Liberal moisturizer use throughout the day
- Limit water exposure and avoid hot baths
- Avoid wool clothing and physical irritants
- Avoid soaps; use emollients for washing
Topical Therapy for Generalized Pruritus of Unknown Origin
Topical doxepin may be prescribed but limit to 8 days, 10% body surface area, maximum 12g daily (contact dermatitis risk) 1
Consider topical clobetasone butyrate or menthol 1
Do NOT use:
- Crotamiton cream (ineffective) 1
- Topical capsaicin (except for uremic pruritus) 1
- Calamine lotion (no evidence) 1
Systemic Therapy (Step 2)
Start with non-sedating antihistamines before sedating agents 1:
- Fexofenadine 180 mg, loratadine 10 mg, or cetirizine 10 mg
- Consider combining H1 + H2 antagonists (e.g., fexofenadine + cimetidine) 1
Sedating antihistamines should be avoided long-term (dementia risk), except in palliative care 1. Use hydroxyzine only short-term if needed 1.
Disease-Specific Treatments
Hepatic Pruritus - Clear Treatment Hierarchy 1:
- First-line: Rifampicin (Strength A)
- Second-line: Cholestyramine
- Third-line: Sertraline
- Fourth-line: Naltrexone or nalmefene
- Fifth-line: Consider dronabinol, phenobarbital, topical tacrolimus, or liver transplantation
Do NOT use gabapentin for hepatic pruritus 1
Uremic Pruritus 1:
- Optimize dialysis, normalize calcium-phosphate, control PTH, correct anemia with erythropoietin
- BB-UVB phototherapy is the most effective treatment (Strength A) 1
- Consider gabapentin, capsaicin cream, or topical calcipotriol
- Cetirizine is NOT effective 1
- Renal transplantation is definitive cure
Polycythemia Vera 1:
- Aspirin 300 mg daily
- Cytoreductive therapy, interferon-alpha, SSRIs
- NB-UVB, BB-UVB, or PUVA (relapses common after stopping)
Lymphoma-Associated Pruritus 1:
- Cimetidine, gabapentin, carbamazepine, or mirtazapine
- Oral corticosteroids for incurable disease
- BB-UVB for Hodgkin lymphoma, NB-UVB for non-Hodgkin lymphoma
Drug-Induced Pruritus 1:
- Opioid-induced: Naltrexone is first-choice (Strength B); alternatives include methylnaltrexone, ondansetron, droperidol, mirtazapine, gabapentin
- Postoperative: Diclofenac 100 mg rectally
- Chloroquine-induced: Prednisolone 10 mg, niacin 50 mg, or combination; consider dapsone
Advanced Systemic Options (Step 3) 1
When first-line treatments fail, consider:
- Paroxetine, fluvoxamine, mirtazapine
- Naltrexone, butorphanol
- Gabapentin, pregabalin
- Ondansetron, aprepitant
- Phototherapy (BB-UVB or NB-UVB)
Critical Pitfalls
- Never diagnose idiopathic pruritus without excluding secondary causes first 1
- Maintain vigilance for evolving symptoms suggesting secondary causes in apparent idiopathic cases 1
- In elderly patients with chronic generalized pruritus, malignancy screening is essential 2
- Avoid long-term sedating antihistamines due to dementia risk 1
- Phototherapy requires multiple sessions—onset of effect typically begins at 2 weeks 1